Literature DB >> 20352472

Treatment-induced leukoencephalopathy in primary CNS lymphoma presenting as lower body parkinsonism.

Antonio Milia1, Giuseppina Pilia, Maria Giuseppina Mascia, Francesco Maria Manconi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352472     DOI: 10.1007/s11060-010-0160-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  7 in total

1.  Delayed neurotoxicity in primary central nervous system lymphoma.

Authors:  Antonio M P Omuro; Leah S Ben-Porat; Katherine S Panageas; Amy K Kim; Denise D Correa; Joachim Yahalom; Lisa M Deangelis; Lauren E Abrey
Journal:  Arch Neurol       Date:  2005-10

Review 2.  Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy.

Authors:  L M DeAngelis
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

3.  Treatment for primary CNS lymphoma: the next step.

Authors:  L E Abrey; J Yahalom; L M DeAngelis
Journal:  J Clin Oncol       Date:  2000-09       Impact factor: 44.544

Review 4.  Subcortical ischaemic vascular dementia.

Authors:  Gustavo C Román; Timo Erkinjuntti; Anders Wallin; Leonardo Pantoni; Helena C Chui
Journal:  Lancet Neurol       Date:  2002-11       Impact factor: 44.182

Review 5.  Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.

Authors:  Rose Lai; Lauren E Abrey; Marc K Rosenblum; Lisa M DeAngelis
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

6.  Lower body parkinsonism: evidence for vascular etiology.

Authors:  P M FitzGerald; J Jankovic
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

7.  Cognitive status and quality of life after treatment for primary CNS lymphoma.

Authors:  H Harder; H Holtel; J E C Bromberg; P Poortmans; H Haaxma-Reiche; H C Kluin-Nelemans; J Menten; M J van den Bent
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

  7 in total
  1 in total

Review 1.  Movement Disorders and Hematologic Diseases.

Authors:  Roshni Abee Patel; Deborah A Hall; Sheila Eichenseer; Meagan Bailey
Journal:  Mov Disord Clin Pract       Date:  2020-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.